Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD at Massachusetts General Hospital, Boston, MA 02114, USA.
Psychol Med. 2010 Jul;40(7):1079-88. doi: 10.1017/S0033291709991437. Epub 2009 Nov 6.
To estimate the spectrum of familial risk for psychopathology in first-degree relatives of children with unabridged DSM-IV bipolar-I disorder (BP-I).
We conducted a blinded, controlled family study using structured diagnostic interviews of 157 children with BP-I probands (n=487 first-degree relatives), 162 attention deficit hyperactivity disorder (ADHD) (without BP-I) probands (n=511 first-degree relatives), and 136 healthy control (without ADHD or BP-I) probands (n=411 first-degree relatives).
The morbid risk (MR) of BP-I disorder in relatives of BP-I probands (MR=0.18) was increased 4-fold [95% confidence interval (CI) 2.3-6.9, p<0.001] over the risk to relatives of control probands (MR=0.05) and 3.5-fold (95% CI 2.1-5.8, p<0.001) over the risk to relatives of ADHD probands (MR=0.06). In addition, relatives of children with BP-I disorder had high rates of psychosis, major depression, multiple anxiety disorders, substance use disorders, ADHD and antisocial disorders compared with relatives of control probands. Only the effect for antisocial disorders lost significance after accounted for by the corresponding diagnosis in the proband. Familial rates of ADHD did not differ between ADHD and BP-I probands.
Our results document an increased familial risk for BP-I disorder in relatives of pediatric probands with DSM-IV BP-I. Relatives of probands with BP-I were also at increased risk for other psychiatric disorders frequently associated with pediatric BP-I. These results support the validity of the diagnosis of BP-I in children as defined by DSM-IV. More work is needed to better understand the nature of the association between these disorders in probands and relatives.
评估未经删减的 DSM-IV 双相情感障碍 I 型(BP-I)患儿一级亲属中精神病理学的家族风险谱。
我们对 157 名 BP-I 先证者(n=487 名一级亲属)、162 名注意力缺陷多动障碍(ADHD,无 BP-I)先证者(n=511 名一级亲属)和 136 名健康对照(无 ADHD 或 BP-I)先证者(n=411 名一级亲属)进行了盲法、对照的家族研究,使用结构化诊断访谈。
BP-I 先证者亲属的 BP-I 障碍发病风险(MR)为 0.18(95%可信区间(CI)2.3-6.9,p<0.001),高于对照组亲属的风险(MR=0.05),也高于 ADHD 先证者亲属的风险(MR=0.06),高出 4 倍(95% CI 2.1-5.8,p<0.001)。此外,与对照组亲属相比,BP-I 障碍患儿的亲属患精神病、重性抑郁、多种焦虑障碍、物质使用障碍、ADHD 和反社会障碍的比率较高。仅在考虑先证者相应诊断后,反社会障碍的家族发病率才失去统计学意义。ADHD 先证者与 BP-I 先证者的 ADHD 家族发病率无差异。
我们的研究结果证明,DSM-IV 诊断的儿科先证者的 BP-I 一级亲属中,BP-I 障碍的家族发病风险增加。BP-I 先证者的亲属也存在其他精神障碍的风险增加,这些障碍常与儿科 BP-I 相关。这些结果支持 DSM-IV 中儿童 BP-I 诊断的有效性。需要进一步研究以更好地理解先证者和亲属中这些障碍之间的关联性质。